Insight Molecular Diagnostics Stock Market Value
| IMDX Stock | 2.57 0.06 2.28% |
| Symbol | Insight |
Insight Molecular Price To Book Ratio
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insight Molecular. If investors know Insight will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insight Molecular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.79) | Revenue Per Share | Quarterly Revenue Growth 11.148 | Return On Assets | Return On Equity |
The market value of Insight Molecular is measured differently than its book value, which is the value of Insight that is recorded on the company's balance sheet. Investors also form their own opinion of Insight Molecular's value that differs from its market value or its book value, called intrinsic value, which is Insight Molecular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insight Molecular's market value can be influenced by many factors that don't directly affect Insight Molecular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insight Molecular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insight Molecular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insight Molecular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Insight Molecular 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Insight Molecular's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Insight Molecular.
| 05/11/2025 |
| 08/09/2025 |
If you would invest 0.00 in Insight Molecular on May 11, 2025 and sell it all today you would earn a total of 0.00 from holding Insight Molecular Diagnostics or generate 0.0% return on investment in Insight Molecular over 90 days. Insight Molecular is related to or competes with Biodesix, Sera Prognostics, Precipio, Applied DNA, Lineage Cell, VTv Therapeutics, and Clearside Biomedical. Insight Molecular is entity of United States More
Insight Molecular Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Insight Molecular's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Insight Molecular Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.44 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 47.86 | |||
| Value At Risk | (6.27) | |||
| Potential Upside | 8.2 |
Insight Molecular Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Insight Molecular's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Insight Molecular's standard deviation. In reality, there are many statistical measures that can use Insight Molecular historical prices to predict the future Insight Molecular's volatility.| Risk Adjusted Performance | 0.0092 | |||
| Jensen Alpha | 0.0872 | |||
| Total Risk Alpha | (0.92) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0082 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Insight Molecular's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Insight Molecular Backtested Returns
At this stage we consider Insight Stock to be dangerous. Insight Molecular holds Efficiency (Sharpe) Ratio of close to zero, which attests that the entity had a close to zero % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Insight Molecular, which you can use to evaluate the volatility of the firm. Please check out Insight Molecular's Risk Adjusted Performance of 0.0092, downside deviation of 4.44, and Market Risk Adjusted Performance of 0.0182 to validate if the risk estimate we provide is consistent with the expected return of 0.0478%. The company retains a Market Volatility (i.e., Beta) of -0.84, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Insight Molecular are expected to decrease at a much lower rate. During the bear market, Insight Molecular is likely to outperform the market. Insight Molecular right now retains a risk of 6.54%. Please check out Insight Molecular value at risk, as well as the relationship between the skewness and day median price , to decide if Insight Molecular will be following its current trending patterns.
Auto-correlation | -0.45 |
Modest reverse predictability
Insight Molecular Diagnostics has modest reverse predictability. Overlapping area represents the amount of predictability between Insight Molecular time series from 11th of May 2025 to 25th of June 2025 and 25th of June 2025 to 9th of August 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Insight Molecular price movement. The serial correlation of -0.45 indicates that just about 45.0% of current Insight Molecular price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.45 | |
| Spearman Rank Test | -0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Insight Molecular lagged returns against current returns
Autocorrelation, which is Insight Molecular stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Insight Molecular's stock expected returns. We can calculate the autocorrelation of Insight Molecular returns to help us make a trade decision. For example, suppose you find that Insight Molecular has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Insight Molecular regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Insight Molecular stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Insight Molecular stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Insight Molecular stock over time.
Current vs Lagged Prices |
| Timeline |
Insight Molecular Lagged Returns
When evaluating Insight Molecular's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Insight Molecular stock have on its future price. Insight Molecular autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Insight Molecular autocorrelation shows the relationship between Insight Molecular stock current value and its past values and can show if there is a momentum factor associated with investing in Insight Molecular Diagnostics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Insight Stock Analysis
When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.